Unless otherwise stated, this product is intended for research use only. It is not suitable for any other purpose, which includes, but is not limited to, unauthorized commercial use, in vitro diagnostic use, or therapeutic use in humans or animals. A Citrate-phosphate-dextrose solution suitable for human use is not currently offered.
Select a Size
| Size/SKU | Availability | Price |
|---|
About This Item
General description
Application
Other Notes
1 of 1
This Item | |||
|---|---|---|---|
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 400 |
| form liquid | form liquid | form liquid | form liquid |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. room temp |
| pH 5.2-5.8 | pH 5.4-6.7 | pH 4.5-5.5 | pH - |
| sterility aseptically filled | sterility sterile-filtered | sterility sterile-filtered | sterility sterile-filtered |
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
-
C7165-50M is suitable for use in humans? I need ACD-A for PRP preparation
1 answer-
Helpful?
-
-
Provide the ingredients if available for CPD Catalog #C7165?
1 answer-
The solution contains 0.30% citric acid anhydrous, 2.63% trisodium citrate dihydrate, 0.193% sodium phosphate monobasic anhydrous, and 2.32% glucose anhydrous, all w/v.
Helpful?
-
-
What is the Department of Transportation shipping information for this product?
1 answer-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
Helpful?
-
-
For the anticoagulant Product C7165, Citrate-Phosphate-Dextrose solution, what is the proper anticoagulant to whole blood ratio to use?
1 answer-
Our search of the literature shows that Citrate-Phosphate-Dextrose solution is typically used at a ratio of 1:7 or 1:9, but we do indeed test it at 1:14...the thinking being that if it works at 1:14, it will surely work at 1:7 or 1:9. The description of Product C7165, Citrate-Phosphate-Dextrose solution, suggests using it at an anticoagulant to whole blood ratio of 1.4 to 10 (about 1:7), but the specification sheet shows that it is tested at an anticoagulant to whole blood ratio of 1:14.
Helpful?
-



